Cite
HARVARD Citation
Vlachogiannakos, J. et al. (n.d.). Long‐term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. Journal of gastroenterology and hepatology. 28 (3), pp. 450-455. [Online].